2-Deoxy-d-glucose Suppresses the In Vivo Antitumor Efficacy of Erlotinib in Head and Neck Squamous Cell Carcinoma Cells

Poor tumor response to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) is a significant challenge for effective treatment of head and neck squamous cell carcinoma (HNSCC). Therefore, strategies that may increase tumor response to EGFR TKIs are warranted in order to improve...

Descripción completa

Detalles Bibliográficos
Autores principales: Sobhakumari, Arya, Orcutt, Kevin P., Love-Homan, Laurie, Kowalski, Christopher E., Parsons, Arlene D., Knudson, C. Michael, Simons, Andrean L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282972/
https://www.ncbi.nlm.nih.gov/pubmed/27178822
http://dx.doi.org/10.3727/096504016X14586627440192

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5282972/
https://www.ncbi.nlm.nih.gov/pubmed/27178822
http://dx.doi.org/10.3727/096504016X14586627440192

Ejemplares similares